Tisseraud, M.; Goutal, S.; Bonasera, T.; Goislard, M.; Desjardins, D.; Le Grand, R.; Parry, C.M.; Tournier, N.; Kuhnast, B.; Caillé, F.
Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging. Pharmaceuticals 2022, 15, 587.
https://doi.org/10.3390/ph15050587
AMA Style
Tisseraud M, Goutal S, Bonasera T, Goislard M, Desjardins D, Le Grand R, Parry CM, Tournier N, Kuhnast B, Caillé F.
Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging. Pharmaceuticals. 2022; 15(5):587.
https://doi.org/10.3390/ph15050587
Chicago/Turabian Style
Tisseraud, Marion, Sébastien Goutal, Thomas Bonasera, Maud Goislard, Delphine Desjardins, Roger Le Grand, Chris M. Parry, Nicolas Tournier, Bertrand Kuhnast, and Fabien Caillé.
2022. "Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging" Pharmaceuticals 15, no. 5: 587.
https://doi.org/10.3390/ph15050587
APA Style
Tisseraud, M., Goutal, S., Bonasera, T., Goislard, M., Desjardins, D., Le Grand, R., Parry, C. M., Tournier, N., Kuhnast, B., & Caillé, F.
(2022). Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging. Pharmaceuticals, 15(5), 587.
https://doi.org/10.3390/ph15050587